Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Compston

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Therapeutic Immunology|August 1, 1995
Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotypeM G Wing, H Waldmann, J Isaacs, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1992
Multiple sclerosis in the Cambridge health district of east AngliaC J Mumford, M B Fraser, N W Wood, et al.
Brain : a Journal of Neurology|September 1, 1978
Factors influencing the risk of multiple sclerosis developing in patients with optic neuritisD A Compston, J R Batchelor, C J Earl, et al.
Tissue Antigens|February 1, 1994
MHC-encoded TAP1 and TAP2 dimorphisms in multiple sclerosisH F Kellar-Wood, S H Powis, J Gray, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1995
Genes and susceptibility to multiple sclerosisD A Compston, H Kellar Wood, N Robertson, et al.
Brain : a Journal of Neurology|May 29, 2000
Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK surveyS A Broadley, J Deans, S J Sawcer, et al.
Neurology|November 1, 1986
Cerebrospinal fluid C9 in demyelinating diseaseD A Compston, B P Morgan, D Oleesky, et al.
Neuroreport|February 15, 1995
A proliferative adult human oligodendrocyte progenitorN J Scolding, P J Rayner, J Sussman, et al.
Journal of Neurology|August 1, 1994
Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disordersJ Roddy, I Clark, B L Hazleman, et al.
Brain : a Journal of Neurology|April 1, 1996
Age-adjusted recurrence risks for relatives of patients with multiple sclerosisN P Robertson, M Fraser, J Deans, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Therapeutic Immunology|August 1, 1995
Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotypeM G Wing, H Waldmann, J Isaacs, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1992
Multiple sclerosis in the Cambridge health district of east AngliaC J Mumford, M B Fraser, N W Wood, et al.
Brain : a Journal of Neurology|September 1, 1978
Factors influencing the risk of multiple sclerosis developing in patients with optic neuritisD A Compston, J R Batchelor, C J Earl, et al.
Tissue Antigens|February 1, 1994
MHC-encoded TAP1 and TAP2 dimorphisms in multiple sclerosisH F Kellar-Wood, S H Powis, J Gray, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1995
Genes and susceptibility to multiple sclerosisD A Compston, H Kellar Wood, N Robertson, et al.
Brain : a Journal of Neurology|May 29, 2000
Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK surveyS A Broadley, J Deans, S J Sawcer, et al.
Neurology|November 1, 1986
Cerebrospinal fluid C9 in demyelinating diseaseD A Compston, B P Morgan, D Oleesky, et al.
Neuroreport|February 15, 1995
A proliferative adult human oligodendrocyte progenitorN J Scolding, P J Rayner, J Sussman, et al.
Journal of Neurology|August 1, 1994
Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disordersJ Roddy, I Clark, B L Hazleman, et al.
Brain : a Journal of Neurology|April 1, 1996
Age-adjusted recurrence risks for relatives of patients with multiple sclerosisN P Robertson, M Fraser, J Deans, et al.
Pageof 12